Clinical Trials
13 trialsNCT06211764 2026-06-05
SunRISe-5
Janssen Research & Development, LLC
Phase 3 Active not recruiting
NCT04375813 2026-06-03
eRapa
The University of Texas Health Science Center at San Antonio
Phase 2 Active not recruiting
NCT05943106 2026-05-26
PATAPSCO
AstraZeneca
Phase 3 Active not recruiting
NCT03933826 2026-05-12
CISTO
University of Washington
Active not recruiting
NCT05243550 2026-05-11
ENVISION
UroGen Pharma Ltd.
Phase 3 Active not recruiting
NCT05538663 2026-05-05
BRIDGE
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting
NCT05981131 2026-04-29
Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)
ImmunityBio, Inc.
Active not recruiting
NCT04917809 2026-04-22
A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT03528694 2026-04-14
POTOMAC
AstraZeneca
Phase 3 Active not recruiting
NCT07511517 2026-04-09
BladMetrix
Oslo University Hospital
Active not recruiting
NCT06253845 2026-04-01
Study of CG0070 After Transurethral Resection in Patients With IR NMIBC
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Active not recruiting
NCT02138734 2026-03-31
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
ImmunityBio, Inc.
Phase 1/2 Active not recruiting
NCT04452591 2026-03-16
BOND-003
CG Oncology, Inc.
Phase 3 Active not recruiting